Diclofenac Sodium API

Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter and manufacturer of Diclofenac Sodium API, supplying high-quality anti-inflammatory APIs to pharmaceutical companies across 40+ international markets. Diclofenac Sodium is a widely used non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain, inflammation, musculoskeletal disorders, and arthritis, making us a reliable Diclofenac Sodium bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Diclofenac Sodium API manufacturers, offering high assay purity, controlled impurity levels, excellent stability, and consistent crystalline quality suitable for tablets, injections, topical formulations, and sustained-release dosage forms. Our expertise in NSAID and pain-management APIs positions us as a dependable Pharmaceutical API exporter.

Our API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis processes, strict impurity profiling, consistent sodium salt formation, and full pharmacopeial compliance for Diclofenac Sodium API.

We export Diclofenac Sodium API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing analgesic and anti-inflammatory medicines. Holiness Pharmaceutical is widely trusted as a bulk Diclofenac Sodium API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent product quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D, process optimization, commercial-scale manufacturing, quality assurance, and global API distribution.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.